Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Drug
BMS Gains European Approval for Opdivo Subcutaneous Formulation
May 29, 2025
Company
Drug
Novartis’ Fabhalta Approved for Previously Treated PNH Patients in China
May 29, 2025
Company
Drug
InnoCare Pharma Gains NMPA Clinical Approval for BCL2 Inhibitor ICP-248
May 29, 2025
Company
Deals
Fosun Pharma and Jiuyuan Gene Partner to Commercialize Biologics in Global Markets
May 29, 2025
Company
Drug
Lupeng Pharma’s Rocbrutinib Near Approval for Mantle Cell Lymphoma
May 29, 2025
Company
Deals
Viva Biotech Establishes RMB 300M Fund for Early-Stage Pharma Projects
May 29, 2025
Company
Drug
Bayer’s Sevabertinib Receives FDA Priority Review for HER2-mutant NSCLC
May 29, 2025
Company
Drug
JW Therapeutics’ Carteyva Receives Fourth sBLA for r/r LBCL
May 29, 2025
Company
Medical Device
Sino Medical Sciences Technology’s AUCURA Flow-Diverting Stent Approved by NMPA
May 29, 2025
Company
Drug
Changchun Pharma Wins FDA Approval for GenSci128 in TP53 Y220C Solid Tumors
May 29, 2025
Company
Drug
Yantai Dongcheng Pharma Gains NMPA Approval for Sodium Fluoride [18F]
May 28, 2025
Company
Deals
Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization
May 28, 2025
1
2
…
348
349
350
351
352
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?